{
    "organizations": [],
    "uuid": "8ff77dade273f3da4336ff88762243d43e79d0ba",
    "author": "",
    "url": "https://www.reuters.com/article/brief-iridian-asset-management-reports-1/brief-iridian-asset-management-reports-10-1-pct-passive-stake-in-eagle-pharmaceuticals-idUSFWN1P30WK",
    "ord_in_thread": 0,
    "title": "BRIEF-Iridian Asset Management Reports 10.1 Pct Passive Stake In Eagle Pharmaceuticals",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 8, 2018 / 8:49 PM / Updated 12 minutes ago BRIEF-Iridian Asset Management Reports 10.1 Pct Passive Stake In Eagle Pharmaceuticals   \nJan 8 (Reuters) - Iridian Asset Management: \n* IRIDIAN ASSET MANAGEMENT REPORTS 10.1 PERCENT PASSIVE STAKE IN EAGLE PHARMACEUTICALS AS OF DEC 31, 2017 - SEC FILING‍​ Source text: ( bit.ly/2AG5uGB ) Further company coverage:",
    "published": "2018-01-08T22:48:00.000+02:00",
    "crawled": "2018-01-08T23:10:52.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "asset",
        "management",
        "report",
        "pct",
        "passive",
        "stake",
        "eagle",
        "pharmaceutical",
        "jan",
        "reuters",
        "iridian",
        "asset",
        "management",
        "iridian",
        "asset",
        "management",
        "report",
        "percent",
        "passive",
        "stake",
        "eagle",
        "pharmaceutical",
        "dec",
        "sec",
        "source",
        "text",
        "company",
        "coverage"
    ]
}